Results

eNauka >  Rezultati >  Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Naziv: Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Autori: Thatcher, Nick; Hirsch, Fred R; Luft, Alexander V; Szczesna, Aleksandra; Ciuleanu, Tudor E; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K; Bálint, Beatrix; Losonczy, György;
Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Kruljac-Letunic, Anamarija; Kurek, Raffael; Paz-Ares, Luis; Socinski, Mark A;
Godina: 2015
Publikacija: The Lancet Oncology
ISSN: 1470-2045 Lancet Oncology Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 16 br. 7 str. 763-774
DOI: 10.1016/s1470-2045(15)00021-2
WoS-ID: 000357273600050
Scopus-ID: 2-s2.0-84937518476
URI: https://enauka.gov.rs/handle/123456789/190808
Izvor metapodataka: Migrirano iz RIS podataka
M-kategorija: 
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+

451
SCOPUSTM
313
OpenCitations
399
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.